Nosadini M, Granata T, Matricardi S, Freri E, Ragona F, Papetti L, et al. Relapse risk factors in anti-N-methyl-d-aspartate receptor encephalitis. Dev Med Child Neurol. 2019;61:1101–7. https://doi.org/10.1111/dmcn.14267.

Article  PubMed  Google Scholar 

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404. https://doi.org/10.1016/S1474-4422(15)00401-9.

Article  PubMed  PubMed Central  Google Scholar 

Dalmau J, Tüzün E, Wu H, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36. https://doi.org/10.1002/ana.21050.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis. 2010;10:835–44. https://doi.org/10.1016/S1473-3099(10)70222-X.

Article  PubMed  Google Scholar 

Maneta E, Garcia G. Psychiatric manifestations of anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications. Psychosomatics. 2014;55:37–44. https://doi.org/10.1016/j.psym.2013.06.002.

Article  PubMed  Google Scholar 

Pollak TA, McCormack R, Peakman M, Nicholson TR, David AS. Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychol Med. 2014;44:2475–87. https://doi.org/10.1017/S003329171300295X.

Article  CAS  PubMed  Google Scholar 

Kayser MS, Dalmau J. Anti-NMDA receptor encephalitis, autoimmunity, and psychosis. Schizophr Res. 2016;176:36–40. https://doi.org/10.1016/j.schres.2014.10.007.

Article  PubMed  Google Scholar 

Tsutsui K, Kanbayashi T, Tanaka K, Boku S, Ito W, Tokunaga J, et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry. 2012;12:37. https://doi.org/10.1186/1471-244X-12-37.

Article  PubMed  PubMed Central  Google Scholar 

Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8. https://doi.org/10.1016/S1474-4422(08)70224-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong R, Chen Q, Zhang X, Zhang H, Lin W. Risk factors for mortality in anti-NMDAR, anti-LGI1, and anti-GABABR encephalitis. Front Immunol. 2022;13: 845365. https://doi.org/10.3389/fimmu.2022.845365.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li A, Gong X, Guo K, Lin J, Zhou D, Hong Z. Direct economic burden of patients with autoimmune encephalitis in western China. Neurol Neuroimmunol Neuroinflammation. 2020. https://doi.org/10.1212/NXI.0000000000000891.

Article  Google Scholar 

Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother. 2015;15:1391–419. https://doi.org/10.1586/14737175.2015.1115720.

Article  CAS  PubMed  Google Scholar 

Lejuste F, Thomas L, Picard G, Desestret V, Ducray F, Rogemond V, et al. Neuroleptic intolerance in patients with anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflammation. 2016;3: e280. https://doi.org/10.1212/NXI.0000000000000280.

Article  Google Scholar 

Forrester A, Latorre S, O’Dea PK, Robinson C, Goldwaser EL, Trenton A, et al. Anti-NMDAR encephalitis: a multidisciplinary approach to identification of the disorder and management of psychiatric symptoms. Psychosomatics. 2020;61:456–66. https://doi.org/10.1016/j.psym.2020.04.017.

Article  PubMed  PubMed Central  Google Scholar 

Samanta D, Lui F. Anti-NMDA receptor encephalitis. Treasure Island: StatPearls; 2023.

Google Scholar 

Kumar A. NMDA receptor function during senescence: implication on cognitive performance. Front Neurosci. 2015. https://doi.org/10.3389/fnins.2015.00473.

Article  PubMed  PubMed Central  Google Scholar 

Adell A. Brain NMDA receptors in schizophrenia and depression. Biomolecules. 2020;10:947. https://doi.org/10.3390/biom10060947.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lakhan SE, Caro M, Hadzimichalis N. NMDA receptor activity in neuropsychiatric disorders. Front Psychiatry. 2013;4:52. https://doi.org/10.3389/fpsyt.2013.00052.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang X, Fan C, Wu J, Ye J, Zhan S, Song H, et al. Clinical analysis on anti-N-methyl-d-aspartate receptor encephalitis cases: Chinese experience. Int J Clin Exp Med. 2015;8:18927–35.

CAS  PubMed  PubMed Central  Google Scholar 

Wang W, Li J-M, Hu F-Y, Wang R, Hong Z, He L, et al. Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China. Eur J Neurol. 2016;23:621–9. https://doi.org/10.1111/ene.12911.

Article  CAS  PubMed  Google Scholar 

Huang Q, Xie Y, Hu Z, Tang X. Anti-N-methyl-d-aspartate receptor encephalitis: a review of pathogenic mechanisms, treatment, prognosis. Brain Res. 2020;1727: 146549. https://doi.org/10.1016/j.brainres.2019.146549.

Article  CAS  PubMed  Google Scholar 

Mann A, Machado NM, Liu N, Mazin A-H, Silver K, Afzal KI. A multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: a case and review of the literature. J Neuropsychiatry Clin Neurosci. 2012;24:247–54. https://doi.org/10.1176/appi.neuropsych.11070151.

Article  CAS  PubMed  Google Scholar 

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74. https://doi.org/10.1016/S1474-4422(10)70253-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157–65. https://doi.org/10.1016/S1474-4422(12)70310-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winter O, Dame C, Jundt F, Hiepe F. Pathogenic long-lived plasma cells and their survival niches in autoimmunity, malignancy, and allergy. J Immunol. 2012;189:5105–11. https://doi.org/10.4049/jimmunol.1202317.

Article  CAS  PubMed  Google Scholar 

Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77. https://doi.org/10.1016/S1474-4422(13)70282-5.

Article  CAS  PubMed  Google Scholar 

Gomes Ferreira M, Lapresa Alcalde V, García Sánchez MH, Hernández Hernández L, Doyague Sánchez MJ. Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: a case report. Medicine (Baltimore). 2018;97: e11325.

Article  PubMed  Google Scholar 

Titulaer MJ, Kayser MS, Dalmau J. Prevalence and treatment of anti-NMDA receptor encephalitis—Authors’ reply. Lancet Neurol. 2013;12:425–6. https://doi.org/10.1016/S1474-4422(13)70072-3.

Article  PubMed  Google Scholar 

Mohammad SS, Jones H, Hong M, Nosadini M, Sharpe C, Pillai SC, et al. Symptomatic treatment of children with anti-NMDAR encephalitis. Dev Med Child Neurol. 2016;58:376–84. https://doi.org/10.1111/dmcn.12882.

Article  PubMed  Google Scholar 

Guang S, Ma J, Ren X, Zhou S, Yang J, Zhang J, et al. Immunotherapies for anti-N-M-methyl-d-aspartate receptor encephalitis: multicenter retrospective pediatric cohort study in China. Front Pediatr. 2021;9: 691599. https://doi.org/10.3389/fped.2021.691599.

Article  PubMed  PubMed Central  Google Scholar 

Kolls BJ, O’Keefe YA, Sahgal AK. Autoimmune encephalitis: NMDA receptor encephalitis as an example of translational neuroscience. Neurotherapeutics. 2020;17:404–13. https://doi.org/10.1007/s13311-020-00861-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turnbull MT, Siegel JL, Becker TL, Stephens AJ, Lopez-Chiriboga AS, Freeman WD. Early bortezomib therapy for refractory anti-NMDA receptor encephalitis. Front Neurol. 2020. https://doi.org/10.3389/fneur.2020.00188.

Article  PubMed  PubMed Central  Google Scholar 

Yang J, Liu X. Immunotherapy for refractory autoimmune encephalitis. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.790962.

Article  PubMed  PubMed Central  Google Scholar 

Nguyen L, Wang C. Anti-NMDA receptor autoimmune encephalitis: diagnosis and management strategies. Int J Gen Med. 2023;16:7–21. https://doi.org/10.2147/IJGM.S397429.